The patented STEP-Technology is applied for the in-situ characterization of particle properties and the direct characterization of the physical formulation stability of adjuvants and vaccines.
Real-time, real-condition stability studies and the accelerated stability studies are discussed on the basis of the WHO Guidelines.
A redispersibility case study on aluminum-containing adjuvants is complemented with information on particle and aggregate sizing, nano particle adsorption and applications related to influenza.
Learn how LUMiReader PSA and LUMiSizer let you follow our slogan: The Next STEP in Dispersion Analysis and Materials Testing.
DATE: 25 June 2020, 9-10 am (UTC 7-8 am)
REGISTRATION LINK:
https://lumgmbh.webex.com/lumgmbh/onstage/g.php?MTID=e12911fadfd8852394e82ea4dffcda33a
DATE: 25 June 2020, 4-5 pm (UTC 2-3 pm)
REGISTRATION LINK:
https://lumgmbh.webex.com/lumgmbh/onstage/g.php?MTID=e0b5ddfafb7436eb4d70cd2116a01f870
LUM GmbH
Justus-von-Liebig-Str. 3
12489 Berlin
Telefon: +49 (30) 6780-6030
Telefax: +49 (30) 6780-6058
http://www.lum-gmbh.com
Sales & Marketing Manager
Telefon: +49 (30) 678060-40
Fax: +49 (40) 678060-58
E-Mail: A.Uhl@lum-gmbh.de